|
|
Other links at Articles > Business of Medicine |
| 4. |
Recentin Fails Lung Cancer Trial
|
|
|
A clinical trial of Recentin as a treatment for non-small-cell lung cancer has been halted by AstraZeneca, Plc, after a mid-stage study failed to meet its main goal, although trials in colorectal cancer will move ahead. Reuters Health Information
|
| 5. |
Merit Medical Gets FDA Nod for Two Devices
|
|
|
Merit Medical Systems Inc, which makes disposable medical devices, said it received regulatory clearance to sell its All Star hemostasis valve and the Prelude marker tip introducer sheath. Reuters Health Information
|
|
|
